'Slow-Growth' Global Trend Shakes Up P&G Product Strategy Start To Finish
Executive Summary
P&G’s health care segment advanced 4% in the third quarter to $1.84bn, but sales declined for its other business units, a trend the firm sees worldwide across consumer industries. CFO Jon Moeller unveils the firm’s “irresistible superiority” product development strategy to counter slower global consumer spending.
You may also be interested in...
Rembrandt Whitening Strips Launch Following P&G Patent Dispute Settlement
Rembrandt 1 Week Whitening Kit cuts in half the time it takes most whitening products to work, says manufacturer Ranir. The launch follows Ranir’s settlement with P&G over its use of two patents for Crest Whitestrips.
P&G Extends Gum Repair Toothpaste Line As It Trims Production Footprint
P&G says harmful plaque bacteria below the gum line evades "even the most the diligent brushers." The firm plans in 2020 to move manufacturing of hair, oral and personal care products from Iowa to a facility in West Virginia.
P&G Extends Gum Repair Toothpaste Line As It Trims Production Footprint
P&G says harmful plaque bacteria below the gum line evades "even the most the diligent brushers." The firm plans in 2020 to move manufacturing of hair, oral and personal care products from Iowa to a facility in West Virginia.